Agenda

Saturday May 11, 2024

• 8:40 AM – 8:45 AM

  Welcome

  • Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
• 8:45 AM – 9:00 AM

  Session 1: Debate- Should Smoldering Myeloma be treated? -YES

  • Speaker
    • Adeel KhanMD, MPH, MS
• 9:00 AM – 9:15 AM

  Session 1: Debate- Should Smoldering Myeloma be treated? -No

  • Speaker
    • Aimaz AfroughMD
• 9:15 AM – 9:25 AM

  Session 1: Panel Discussion

  • Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
  • Panelist
    • Adeel KhanMD, MPH, MS
    • Aimaz AfroughMD
• 9:25 AM – 9:55 AM

  Session 2: An approach to Frontline Therapy

  • Speaker
    • Joseph MikhaelMD, MEd, FRCPC, FACP
• 9:55 AM – 10:05 AM

  Session 2: Panel Discussion

  • Invited Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
• 10:05 AM – 10:20 AM

  Session 3: Debate– Should CAR T cell therapy be used as early as possible? - YES

  • Speaker
    • Jonathan KaufmanMD
• 10:20 AM – 10:35 AM

  Session 3- Debate– Should CAR T cell therapy be used as early as possible? - No

  • Speaker
    • Gurbakhash KaurMD
• 10:35 AM – 10:45 AM

  Session 3: Panel Discussion

  • Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
  • Panelist
    • Gurbakhash KaurMD
    • Jonathan KaufmanMD
• 10:45 AM – 11:15 AM

  Exhibit Hall Break

• 11:15 AM – 11:45 AM

  Session 4 - Making Sense of Relapsed Therapy

  • Speaker
    • Larry AndersonMD, PhD, FACP
• 11:45 AM – 11:55 AM

  Session 4: Panel Discussion

  • Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
  • Speaker
    • Larry AndersonMD, PhD, FACP
• 11:55 AM – 12:25 PM

  Session 5: Practical Management of CAR T Cell Therapy and Bispecific Antibodies

  • Speaker
    • Krina PatelMD, MSc
• 12:25 PM – 12:35 PM

  Session 5: Panel Discussion

  • Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
  • Panelist
    • Krina PatelMD, MSc
• 12:35 PM – 12:45 PM

  Exhibit Hall Break

• 12:45 PM – 1:45 PM

  Non-CME Innovation Theater: Discover CARVYKTI®

• 1:45 PM – 2:00 PM

  Session 6: Debate- Is BCMA therapy followed by another BCMA therapy appropriate? - YES

  • Speaker
    • Robert OrlowskiMD,, PhD
• 2:00 PM – 2:15 PM

  Session 6: Debate- Is BCMA therapy followed by another BCMA therapy appropriate? - No

  • Speaker
    • Susan BalMD
• 2:15 PM – 2:25 PM

  Session 6: Panel Discussion

  • Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
  • Panelist
    • Robert OrlowskiMD,, PhD
    • Susan BalMD
• 2:25 PM – 2:55 PM

  Exhibit Hall Break

• 2:55 PM – 3:25 PM

  Session 7: The Importance of Supportive Care in Myeloma

  • Speaker
    • Gabriel HinojosaPharmD, BCOP
• 3:25 PM – 3:35 PM

  Session 7: Panel Discussion

  • Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
  • Panelist
    • Gabriel HinojosaPharmD, BCOP
• 3:35 PM – 3:50 PM

  Session 8: Debate – Should MRD guide therapy? - YES

  • Speaker
    • Matthew ButlerMD
• 3:50 PM – 4:05 PM

  Session 8: Debate – Should MRD guide therapy? - No

  • Speaker
    • Rafat AbonourMD
• 4:05 PM – 4:15 PM

  Session 8: Panel Discussion

  • Invited Panelist
    • Rafat AbonourMD
  • Moderator
    • Joseph MikhaelMD, MEd, FRCPC, FACP
  • Panelist
    • Matthew ButlerMD